Showing results (361-370 of 405) with videos related to

Sort By:
Pageof 41
Arthritis Care & Research|October 16, 2018
Prospective Determination of the Incidence and Risk Factors of New-Onset Uveitis in Juvenile Idiopathic Arthritis: The Research in Arthritis in Canadian Children Emphasizing Outcomes CohortJennifer J Y Lee, Ciarán M Duffy, Jaime Guzman, et al.
Clinical Genetics|August 15, 2008
LAMA2 gene analysis in a cohort of 26 congenital muscular dystrophy patientsJ Oliveira, R Santos, I Soares-Silva, et al.
Pediatric Rheumatology Online Journal|May 9, 2026
Speaking the same language: international cross-validation of emerging biomarkers for juvenile idiopathic arthritis and Still's DiseaseMichael G Matt, Sabrina Fuehner, Thuy Do, et al.
Nature|January 7, 2021
In vivo base editing rescues Hutchinson-Gilford progeria syndrome in miceLuke W Koblan, Michael R Erdos, Christopher Wilson, et al.
Clinical Immunology (Orlando, Fla.)|January 4, 2017
The importance of considering monogenic causes of autoimmunity: A somatic mutation in KRAS causing pediatric Rosai-Dorfman syndrome and systemic lupus erythematosusRobert J Ragotte, Anita Dhanrajani, Julian Pleydell-Pearce, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 25, 2015
Incident Vertebral Fractures and Risk Factors in the First Three Years Following Glucocorticoid Initiation Among Pediatric Patients With Rheumatic DisordersClaire M A LeBlanc, Jinhui Ma, Monica Taljaard, et al.
Canadian Journal of Kidney Health and Disease|November 12, 2015
CanVasc recommendations for the management of antineutrophil cytoplasm antibody (ANCA)-associated vasculitides - Executive summaryLucy McGeoch, Marinka Twilt, Leilani Famorca, et al.
Arthritis Care & Research|May 11, 2019
Real-World Effectiveness of Common Treatment Strategies for Juvenile Idiopathic Arthritis: Results From a Canadian CohortAmieleena Chhabra, Kiem Oen, Adam M Huber, et al.
Arthritis Care & Research|October 28, 2024
Comparing Rituximab and Cyclophosphamide in Induction Therapy for Childhood-Onset Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: An ARChiVe Registry Cohort StudySamuel J Gagne, Vidya Sivaraman, Else S Bosman, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 4, 2017
Early Outcomes in Children With Antineutrophil Cytoplasmic Antibody-Associated VasculitisKimberly A Morishita, Lakshmi N Moorthy, Joanna M Lubieniecka, et al.
Pageof 41